financetom
Business
financetom
/
Business
/
Market Chatter: Berkshire Hathaway Affiliate GEICO's Defense in Repairs Claims Slammed by Florida Justices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Berkshire Hathaway Affiliate GEICO's Defense in Repairs Claims Slammed by Florida Justices
May 8, 2024 1:03 PM

03:52 PM EDT, 05/08/2024 (MT Newswires) -- Berkshire Hathaway (BRK.A) affiliate GEICO's defense in a claim payment lawsuit against windshield repair company Glassco appears to be lacking statutory support, according Florida Supreme Court justices, Bloomberg reported Wednesday.

Glassco has been accused of using a loophole in state law for overcharging insurance companies, while taking advantage of no-deductible repairs, according to the report.

GEICO accused Glassco of violating Florida's Repair Act in a counter lawsuit after the latter filed a case against GEICO in 2019 for alleged underpayment of claims for auto glass repairs between 2016 and 2019.

The justices said the issue with the insurance industry's argument is that the system seems to be legal under Florida state laws and GEICO does not fall under the term "customer" who can claim damages for over charging on repair fees.

Berkshire didn't immediately reply to MT Newswires' request for comment, while GEICO and Glassco could not be reached.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellantis' Fiat Chrysler Automobiles to Recall Over 1 Million US Vehicles Over Rearview Camera Issue
Stellantis' Fiat Chrysler Automobiles to Recall Over 1 Million US Vehicles Over Rearview Camera Issue
Jun 18, 2024
07:31 AM EDT, 06/18/2024 (MT Newswires) -- Stellantis' ( STLA ) Fiat Chrysler Automobiles is planning to recall 1,033,433 vehicles because of an issue with rearview cameras that prevents images from displaying, increasing the risk of a crash, the US National Highway Traffic Safety Administration said in a letter of acknowledgement posted on its website and sent to Stellantis' (...
Canada's TD Bank launches tech-focused banking unit
Canada's TD Bank launches tech-focused banking unit
Jun 18, 2024
June 18 (Reuters) - Toronto-Dominion Bank ( MLWIQXX ), Canada's second-largest bank, launched a new business focused on providing banking and financing services to technology companies in its domestic market. The bank, which has been facing regulatory push back for alleged non-compliance with anti-money laundering regulations, intends to boost its presence in a highly saturated local market by expanding its...
Patterson Fiscal Q4 Adjusted Earnings Fall, Net Sales Remain Unchanged; Fiscal 2025 Non-GAAP EPS Guidance Issued
Patterson Fiscal Q4 Adjusted Earnings Fall, Net Sales Remain Unchanged; Fiscal 2025 Non-GAAP EPS Guidance Issued
Jun 18, 2024
07:56 AM EDT, 06/18/2024 (MT Newswires) -- Patterson Companies ( PDCO ) reported fiscal Q4 adjusted earnings Tuesday of $0.82 per diluted share, down from $0.84 a year earlier. Analysts polled by Capital IQ expected $0.82. Net sales for the fiscal quarter ended April 27 were $1.72 billion, virtually unchanged from a year earlier. Analysts surveyed by Capital IQ expected...
US FDA puts partial clinical hold on Zentalis' cancer drug studies; shares drop
US FDA puts partial clinical hold on Zentalis' cancer drug studies; shares drop
Jun 18, 2024
June 18 (Reuters) - Zentalis Pharmaceuticals ( ZNTL ) said on Tuesday the U.S. Food and Drug Administration has placed a partial clinical hold on three studies testing its cancer drug, following the death of two trial participants. Shares of the drug developer slumped about 30% to $5.88 in premarket trading. The drug, azenosertib, was being tested against solid tumors...
Copyright 2023-2026 - www.financetom.com All Rights Reserved